Infusion Therapy Market Analysis, Size, Trends | Global | 2018-2024 | MedSuite

Industry Trends

One major driver in the infusion therapy market is the development of “smart” pumps that monitor doses through pre-programmed drug libraries and determine unit calculations automatically when a drug is selected. These smart pumps lessen complications due to improper dosages and also allow the automatic updating of electronic medical records because of their connection to the electronic system. As medical records become more automated, it is expected that infusion pumps will become increasingly automated as well. As electronic medical records and smart pumps increase their penetration into the European market, the infusion pump market will be de-commoditized and the ASP is expected to be sustained.

In the coming years, infusion therapy will continue to be an increasingly effective method of treatment, presenting opportunities for both industry veterans and new entrants. Corporate consolidation will increase overall R&D spending and lead to the development of more effective and efficient devices, further growing the market volume and penetration.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

• • United States
  • Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Asia-Pacific

The Only Medical Device Market Research With:
✔ Unit Sales Growth Analysis ✔ Average Selling Prices ✔ Competitor Shares by Segment & Country ✔ SKU-Level Research Methods ✔ The Lowest Acquisition Cost	Request a FREE Sample Report

Highly Detailed Segmentation

While this report suite contains all applicable infusion therapy market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the infusion therapy market research that you need. You can view all these included reports and segmentation here:

• Infusion Pump Market – MedCore
• Intravenous Sets Market – MedCore
• Needleless Connectors Market – MedCore
• Intravenous Filters Market – MedCore
• IV Line Stopcocks Market – MedCore
• Blood Transfusion Sets Market – MedCore

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Full Segmentation Map for the United States

Data Types Included

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• 10 Year Scope and Forecast Range
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

Infusion Therapy Devices Market Share Insights

In the United States infusion therapy market, Becton Dickinson leads the way. In 2015, Becton Dickinson acquired CareFusion, who was a market leader in the infusion therapy market. Since then, Becton Dickinson has marketed infusion therapy devices, manufactured by its CareFusion unit, under a Becton Dickinson brand name. By 2017, Becton Dickinson had a strong share in many of the infusion therapy market segments.

Becton Dickinson’s Alaris® product line has several large volume infusion models, including the Alaris® SE device. This devices unique software reduces errors due to improper dosage, which improves patient care and compliance with national safety standards.

Although Becton Dickinson still holds a decent share, the European market is led by B. Braun. Their market dominance in Europe is was driven by its leadership in key markets like Germany and Italy. B. Braun is expected to maintain their strong position in the large volume and syringe infusion pump markets and, as result, maintain its leading position in the intravenous set markets across Europe.

All Companies Analyzed in this Study

3M Ace Medical Acromed Actimed Amadeus AmbIT Ambu AMS Ltd. UK Amsino Applied Medical Arcomed Argon Medical Devices Aries Srl B. Braun Baxter Becton Dickinson (CareFusion) Beijing Eternity Electronics Beijing Fert Technology Beijing Kelijianyuan Beijing KellyMed Beijing Xin He Feng Benefis Srl Bexen Medical Biolena Srl Biolight BMS Critical Care BQ Plus C.V. Medica Cair Centurion Medicap Products Changsha BEYOND Medical Changsha Epower Electronic CME Codan Comedical Crest Medical Dai Wha Delta Med S.p.A Didactic Doran eBangy Technology Ecomed HK Elcam Electronics & Science CO Elkam Medical USA Ewha Excelsior Medical Fannin Ferrari L. Medical Devices Foures Fresenius Go Medical Guangzhou Huaxi Guangzhou Upreal Medical GVS Group Haemonetics Halyard Halyard Health Henan Shuguang Jianshi Hengchun Medical Product HMD Medical Hospira

Huichun Medical Equipment ICU Medical I-Flow IMS Euro Intervene Iradimed ITW Filtertek Ivenix Corporation JianYuan Jinta Medical JMS Kimal Klinicom Srl Leventon Macropharm Srl McKinley Medical Medima Mediplus Medispo Medtronic Merck Millipore Micrel Mindray MJY Enterprise Moog Corporation Multimedia Srl NewTech Medical Nexus Medical NIPRO Pall Corporation PICC Excellence Plenum Technologies Poly Medicure Qinhuangdao Contec Qosina Rays S.p.A Royal Fornia Medical Rymed Technologies S.M.D. Samtronic Sares Shanghai Angel Shenzhen Brand Meditech Shenzhen Osen Technology Shenzhen Shenke Shermond Sinomdt Smiths Medical Summit Medical Products Suzhou Lingyan Medical Devices Suzhou Zede Medical Teleflex Terumo Venner Medical Vygon WalkMed Walkmed Infusion WooYoung Medical Xinhefeng Medical Zhejiang FERT Zhejiang Runqiang Zyno Medical Products

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

UNITED STATES TABLE OF CONTENTS

LIST OF FIGURES VI
LIST OF CHARTS X
EXECUTIVE SUMMARY 15
U.S. INFUSION THERAPY DEVICES MARKET OVERVIEW 15
COMPETITIVE ANALYSIS 18
MARKET TRENDS 20
MARKET DEVELOPMENTS 21
MARKETS INCLUDED 22
KEY REPORT UPDATES 23
VERSION HISTORY 23
RESEARCH METHODOLOGY 24
1.1 RESEARCH SCOPE 24
1.2 IDATA’S 9-STEP METHODOLOGY 24
Step 1: Project Initiation & Team Selection 24
Step 2: Prepare Data Systems and Perform Secondary Research 26
Step 3: Preparation for Interviews & Questionnaire Design 27
Step 4: Performing Primary Research 28
Step 5: Research Analysis: Establishing Baseline Estimates 30
Step 6: Market Forecast and Analysis 31
Step 7: Identify Strategic Opportunities 33
Step 8: Final Review and Market Release 34
Step 9: Customer Feedback and Market Monitoring 35

U.S. INFUSION THERAPY DEVICES MARKET OVERVIEW

2.1 INTRODUCTION 36
2.2 MARKET OVERVIEW 39
2.3 TREND ANALYSIS BY SEGMENT 43
2.4 DRIVERS AND LIMITERS 46
2.4.1 Market Drivers 46
2.4.2 Market Limiters 48
2.5 COMPETITIVE MARKET SHARE ANALYSIS 52

INFUSION PUMP MARKET

3.1 INTRODUCTION 59
3.1.1 Statistics 61
3.2 MARKET OVERVIEW 64
3.3 MARKET ANALYSIS AND FORECAST 69
3.3.1 Large Volume Infusion Pump Market 69
3.3.1.1 Large Volume Infusion Pump Market by Care Setting 72
3.3.1.1.1 Acute Care Market 75
3.3.1.1.2 Alternate Care Market 77
3.3.1.2 Large Volume Infusion Pump Market by Channels 79
3.3.1.2.1 Single Channel Pump Market 82
3.3.1.2.2 Multi-Channel Pump Market 84
3.3.2 Syringe Infusion Pump Market 86
3.3.2.1 Syringe Infusion Pump Market by Care Setting 88
3.3.2.1.1 Acute Care Market 91
3.3.2.1.2 Alternate Care Market 93
3.3.2.2 Syringe Infusion Pump Market by Channels 95
3.3.2.2.1 Single Channel Pump Market 98
3.3.2.2.2 Multi-Channel Pump Market 100
3.3.3 Patient-Controlled Analgesia Infusion Pump Market 102
3.3.3.1 Patient-Controlled Analgesia Infusion Pump Market by Care Setting 104
3.3.3.1.1 Acute Care Market 107
3.3.3.1.2 Alternate Care Market 109
3.3.4 Electronic Ambulatory Infusion Pump Market 111
3.3.5 Disposable Ambulatory Infusion Pump Market 113
3.3.5.1 Disposable Ambulatory Infusion Pump by Type 116
3.3.5.1.1 Disposable Ambulatory Infusion Non-Pain Pump Market 120
3.3.5.1.2 Disposable Ambulatory Infusion Pain Pump Market 122
3.4 DRIVERS AND LIMITERS 131
3.4.1 Market Drivers 131
3.4.2 Market Limiters 134
3.5 COMPETITIVE MARKET SHARE ANALYSIS 137

INTRAVENOUS SET MARKET

4.1 INTRODUCTION 144
4.2 MARKET OVERVIEW 146
4.3 MARKET ANALYSIS AND FORECAST 150
4.3.1 Primary IV Set Market 150
4.3.2 Primary IV Set by Type 152
4.3.2.1 Dedicated Primary IV Set Market 155
4.3.2.1.1 Dedicated Primary IV Set Market by Type 157
4.3.2.1.2 General Ward Primary Set Market 173
4.3.2.2 Non-Dedicated Primary IV Set Market 175
4.3.3 Primary IV Set Market by Setting 177
4.3.3.1 Acute Care Market 180
4.3.3.2 Alternate Care Market 182
4.3.4 IV Extension Set Market 184
4.3.4.1 IV Extension Set by Setting 186
4.3.4.1.1 Acute Care Market 189
4.3.4.1.2 Alternate Care Market 191
4.3.5 Gravity Set Market 193
4.3.5.1 Gravity Set by Type 195
4.3.5.1.1 Gravity Administration Set Market 198
4.3.5.1.2 Gravity Transfusion Set Market 200
4.3.6 Secondary IV Set Market 202
4.3.6.1 Secondary IV Set Market by Setting 204
4.3.6.1.1 Acute Care Market 207
4.3.6.1.2 Alternate Care Market 209
4.3.7 DEHP IV Sets Market 211
4.3.8 Non-DEHP IV Sets Market 213
4.4 DRIVERS AND LIMITERS 215
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS 218

NEEDLELESS CONNECTOR MARKET

5.1 INTRODUCTION 221
5.2 MARKET OVERVIEW 225
5.3 MARKET ANALYSIS AND FORECAST 235
5.3.1 Total Needleless Connector Market 235
5.3.2 Needleless Connector Market by Valve Type 237
5.3.2.1 Split Septum & Blunt Cannula NLC Market 237
5.3.2.2 Total Mechanical Valve NLC Market 239
5.3.2.2.1 Mechanical Valve NLC Market by Type 241
5.3.3 Needleless Connector Market by Device Type 254
5.3.3.1 Standalone NLC Market 254
5.3.3.2 Integrated NLC Market 256
5.3.4 Needleless Connector Market by Setting 258
5.3.4.1 Acute Care Market 258
5.3.4.2 Alternate Care Market 260
5.4 DRIVERS AND LIMITERS 262
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS 264

INTRAVENOUS FILTER MARKET

6.1 INTRODUCTION 268
6.2 MARKET ANALYSIS AND FORECAST 270
6.3 DRIVERS AND LIMITERS 273
6.3.1 Market Drivers 273
6.3.2 Market Limiters 273
6.4 COMPETITIVE MARKET SHARE ANALYSIS 275

BLOOD TRANSFUSION MARKET

7.1 INTRODUCTION 278
7.2 MARKET ANALYSIS AND FORECAST 279
7.3 DRIVERS AND LIMITERS 281
7.3.1 Market Drivers
7.3.2 Market Limiters 281
7.4 COMPETITIVE MARKET SHARE ANALYSIS 282

ABBREVIATIONS

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

• Original primary research that consists of the most up-to-date market data
• Strong foundation of quantitative and qualitative research
• Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology